Laurence Pezor, MD
Psychiatry · Denton, MDNPI 1427055946
Payments from drug & device makers
Across 111 payments — averaging $44.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$3K
- Ironshore Pharmaceuticals Inc.$631
- Otsuka America Pharmaceutical, Inc.$271
- Johnson & Johnson$218
- Tris Pharma Inc$138
- Takeda Pharmaceuticals U.S.A., Inc.$128
- plus $538 from 9 others
What the payments were for
- Speaking & faculty fees$2,90059%
- Food & beverage$2,03541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 9 | $3,012 |
| Ironshore Pharmaceuticals Inc. | 44 | $631 |
| Otsuka America Pharmaceutical, Inc. | 11 | $271 |
| Johnson & Johnson | 8 | $218 |
| Tris Pharma Inc | 7 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $128 |
| AbbVie(2 entities) | 3 | $105 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| Lundbeck LLC | 3 | $71 |
| Sunovion Pharmaceuticals Inc. | 4 | $71 |
| Alkermes, Inc. | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Neurocrine Biosciences, Inc. | 2 | $32 |
| Shire North American Group Inc | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
How this compares
$4,935 in reported general payments places this provider in the 90th percentile of 851 psychiatry providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paliperidone ErPaliperidone | 36 | $10,282 |
| Aripiprazole | 30 | $2,584 |
| Ziprasidone Hcl | 25 | $329 |
| Olanzapine | 11 | $211 |
| Benztropine Mesylate | 18 | $198 |
| Carbamazepine | 12 | $194 |
| Hydroxyzine Hcl | 16 | $182 |
| Quetiapine Fumarate | 19 | $164 |
| Prazosin Hcl | 16 | $152 |
| Fluvoxamine Maleate | 12 | $139 |
| Lithium Carbonate ErLithium Carbonate | 13 | $138 |
| Lamotrigine | 17 | $98 |
| Clonazepam | 24 | $49 |
| Mirtazapine | 13 | $39 |
| Fluoxetine Hcl | 27 | $36 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Denton
- Elia Acevedo DiazGaithersburg$15.8M
- Akira SawaBaltimore$5.1M
- John VaethBaltimore$2.1M
- Paul RosenbergBaltimore$1.9M
- Scott AaronsonBaltimore$1.3M
- Karen AndersonBaltimore$1.1M
- Constantine LyketsosBaltimore$1.1M
- Alan JonasBaltimore$1.1M
- Sarah HertsBaltimore$1M
- Robert LehmanBaltimore$947K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.